In another strategic move, MMJ International Holdings (MMJ), a premier medical cannabis company based in the United States and Jamaica, is collaborating with Northern Caribbean University (NCU). In the last year, MMJ has made the news for being in the running for a marijuana grow license from the DEA and advancing in that process. The DEA’s stringent guidelines for licensing require that the applicant must demonstrate a case to meet the public interest, such as FDA filings for the development of a pharmaceutical. MMJ has been developing a cannabis-based drug to treat multiple sclerosis and Huntington’s disease and has filed for clinical trial approval with the FDA. Additionally, the company has planned to cultivate their crop on Native American land, which offers benefits for both parties such as economic development on the tribal lands and flexible regulatory environments for MMJ.

By collaborating with NCU, MMJ is helping the university with cannabis education, analytics lab set-up, and cultivation This agreement allows for the establishment of a sustainable plan of action for the delivery of services through the university. These services include the development of cannabinoid research protocol, the medicinal product design, and more. Medical cannabis need not exist in a bubble as a niche market – as it grows more popular and effective, cannabis-derivatives will reshape the modern medical landscape. 

The partnership provides tangible benefits to both the educational institution and the research company. In addition, together MMJ and NCU are planning to acquire specific plant-genetic materials, instituting a marketing plan for their products, and developing a telemedicine platform, patient health records, and remote patient monitoring system that works with the university, hospitals, medical offices, and patients. Duane Boise, CEO of MMJ, said of the agreement, “We are looking forward to making Jamaica a pharmaceutical supply hub and collaborate with NCU in unlocking the potential of cannabinoid medicines to address serious patient medical conditions.”

Boise further emphasized that their efforts will be strictly guided by FDA and DEA policy as MMJ and NCU strive to produce the highest grade plants and extracts for manufacturing and clinical research. He sees many ways that the joint venture is beneficial: students of biochemistry and molecular biology would get the opportunity to assist pharmaceutical companies, nurses would be trained to administer and monitor patients using medical marijuana, and agricultural students would learn about cultivation technology. By sharing in the resources of the educational institution, MMJ is providing the students and staff of Northern Caribbean University with real-world opportunities to get involved in the rapidly growing cannabis industry.